N/ A
Cancer Treatment/ Diagnostic Tests
Inj. Trastuzumab 440 mg, Inj. Phesgo Trastuzumab plus Pertuzumab 600 plus 600 mg by10ml, Inj. Palonosteron 0. 25mg, Inj. 5 Flurouracal 500 mg, Inj. Cyclophosphamide 500mg, Inj. Pegfilgastrim 6 mg 0. 6ml, Genotype MTBDRSL Ver 2. 0 Line Probe Assay for Second Line Drug Drug Resistance Testing Under NTEP, Genotype Mycobacterium as ver 2. 0 Detection of M Tuberculosis Complex and More than 20 Clinically Relevant NTM from Cultures
Tender Close Date: